According to our report, the Pharmaceutical Filtration Market size in the Asia Pacific was valued at USD 3.62 billion in 2022. It is estimated to be growing at a CAGR of 11.3% and worth USD 6.18 billion by 2027.
The increasing prevalence of chronic diseases, rabies, polio, and malaria are driving the APAC pharmaceutical filtration market. Also, the market is expected to grow as the focus on biologics and their development for the treatment of various diseases increases. Other factors such as rising healthcare spending, improving infrastructure and increasing research and development activities fuel market growth. Increasing government initiatives, funding for the development of healthcare infrastructure, and rise in investments by major market players in emerging economies are significantly contributing to the regional market growth.
The rise in the therapeutic biopharmaceuticals such as hormones, antibodies, and vaccines; technological breakthroughs in nanofiltration technology, the surge in demand for single-use technologies, an increase in healthcare research and development expenditure, and an increase in the number of pharmaceutical companies are some of the factors that drive the growth of the pharmaceutical filtration market.
Furthermore, the pharmaceutical filtration market is expected to grow due to an increase in the frequency of chronic diseases, strong biological pipeline products, and an increased need for filters in the pharmaceutical and biopharmaceutical industries. Pharmaceutical filtration offers various advantages such as high speed, low energy consumption, and limited operation pressure boost the market growth. Increased product sales in a specific market and demand for pharmaceutical filtration in developing countries provide industry participants with profitable potential.
However, the pharmaceutical filtration market in the APAC region is likely to be hampered by high capital needs and strict validation and qualification procedures in various countries during the forecast period.
This research report on the Asia Pacific pharmaceutical filtration market has been segmented and sub-segmented into the following categories:
The pharmaceutical filtration market in the Asia Pacific is expected to increase during the forecast period. The Pacific's pharmaceutical filtration market is primarily due to the region’s large population, higher disposable income, and increased occurrence of chronic diseases such as malaria, polio, and rabies. Furthermore, the rising demand for pharmaceutical filtration market’s expansion throughout the region.
Due to the drug manufacturers’ increasing presence in developing nations such as China and India, the Asia Pacific region is predicted to grow at the fastest CAGR over the projection period. Because of the advancements in the healthcare infrastructure, increased manufacturing of APIs and biologics, and increasing research and developing sector, China is expected to rise steadily in the market. Furthermore, China’s pharmaceutical filtration market is predicted to be driven by a large population base, a rising need for sophisticated medical facilities, and pharmaceutical research and development activities.
However, in Japan, the aging population has put a strain on government healthcare spending. This has prompted the government to enact certain cost-effective strategies, such as generic medicine marketing and drug pricing modifications every two years. In addition, the growing demand for generic drugs has prompted major joint ventures to meet the high demand. As a result of these reasons, demand for pharmaceutical filtration products is increasing, propelling the Japanese pharmaceutical filtration market.
Thailand’s government aspires to be a world-class medical care supplier and a top exporter of medicines and medical devices. The increasing pharmaceutical sector is also due to the country’s compliance with the Pharmaceutical Inspection Cooperation Scheme (PIC/S) manufacturing requirements. The latter established best practices for medical product distribution and production. As a result, the country is expected to become a desirable partner for multinational pharmaceutical companies with such criteria in place. Such elements are predicted to improve Thailand’s market growth.
KEY MARKET PLAYERS:
Companies playing a dominant role in the APAC pharmaceutical filtration market profiled in the report are Merck KGaA, Pall Corporation, GE Healthcare, 3M Company, Parker Hannifin Corporation, Sartorius Stedim Biotech S.A., Eaton Corporation PLC, Graver Technologies, LLC, Amazon Filters Ltd., and Meissner Filtration Products, Inc.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com